# A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

> **NCT06323928** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **H. Lundbeck A/S** · enrollment: 874 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Lu AG09222
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06323928
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-01-16
- **Final completion:** 2026-04-30
- **Target enrollment:** 874 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06323928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06323928, "A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06323928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*